Cvs Pharmacy #16219 Durable Medical Equipment & Medical Supplies Location: 2901 S Cicero Ave, Cicero, Illinois 60804 Phone: (708) 863-6833 |
Sams Pharmacy 10-6328 Durable Medical Equipment & Medical Supplies Location: 2601 S Cicero Ave, Cicero, Illinois 60804 Phone: (708) 652-8596 |
Walgreens #1249 Durable Medical Equipment & Medical Supplies Location: 4800 W Cermak Rd, Cicero, Illinois 60804 Phone: (708) 863-7734 |
Walgreens #16093 Durable Medical Equipment & Medical Supplies Location: 3040 S Cicero Ave, Cicero, Illinois 60804 Phone: (708) 391-2118 |
Walgreens #2785 Durable Medical Equipment & Medical Supplies Location: 5840 W 35th St, Cicero, Illinois 60804 Phone: (708) 780-7513 |
Walgreens #5103 Durable Medical Equipment & Medical Supplies Location: 5932 W Cermak Rd, Cicero, Illinois 60804 Phone: (708) 652-4856 |
Wal-mart Pharmacy 10-3004 Durable Medical Equipment & Medical Supplies Location: 3320 S Cicero Ave, Cicero, Illinois 60804 Phone: (708) 735-8457 |
News Archive
Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced the publication of a scientific paper titled "Spontaneous Reversal of Developmental Aging in Normal Human Cells Following Transcriptional Reprogramming."
An Amercian study has shown sexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to case-control studies, which may be prone to bias because recall among individuals with prostate cancer could be distorted as a consequence of prostate malignancy or ongoing therapy.
A diet high in red meat and alcohol may triple the risk of relapse in patients with the inflammatory bowel disease ulcerative colitis, suggests research in Gut.
Phase I/II clinical trial data support the use of bosutinib as second- or third-line tyrosine kinase inhibitor therapy in Japanese patients with Philadelphia chromosome-positive chronic myeloid leukaemia.
› Verified 5 days ago